BioMarin Pharmaceutical, Inc. (BMRN)
60.07
+1.20
(+2.04%)
USD |
NASDAQ |
Jan 06, 16:00
60.07
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Price: 60.07 for Jan. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.28 |
| Gilead Sciences, Inc. | 121.35 |
| Merck & Co., Inc. | 108.88 |
| AbbVie, Inc. | 224.20 |
| Bristol Myers Squibb Co. | 54.44 |
Price Related Metrics
| PE Ratio | 22.51 |
| PS Ratio | 3.807 |
| PEG Ratio | 0.3707 |
| Price to Book Value | 1.905 |
| Price to Free Cash Flow | 14.22 |
| Earnings Yield | 4.44% |
| Market Cap | 11.54B |
| PEGY Ratio | 0.3707 |
| Operating PE Ratio | 13.73 |
| Normalized PE Ratio | 16.83 |